March 10 (SeeNews) - North Macedonia's pharmaceuticals producer Replek [MSE:REPL] made a net profit of 59.7 million denars ($1.1 million/968,000 euro) last year, down 42% on an annual comparison basis, as costs grew faster than revenues.